Literature DB >> 17624304

The green tea component EGCG inhibits RNA polymerase III transcription.

Joby Jacob1, Stephanie Cabarcas, Ingrid Veras, Nurulain Zaveri, Laura Schramm.   

Abstract

RNA polymerase III (RNA pol III) transcribes many small structural RNA molecules involved in RNA processing and translation, and thus regulates the growth rate of a cell. Accurate initiation by RNA pol III requires the initiation factor TFIIIB. TFIIIB has been demonstrated to be regulated by tumor suppressors, including ARF, p53, RB, and the RB-related pocket proteins, and is a target of the oncogene c-myc and the mitogen-activated protein kinase ERK. EGCG has been demonstrated to inhibit the growth of a variety of cancer cells, induce apoptosis and regulate the expression of p53, myc, and ERK. Thus, we hypothesized that EGCG may regulate RNA pol III transcription in cells. Here, we report that EGCG (1) inhibits RNA pol III transcription from gene internal and gene external promoters (2) EGCG inhibits protein expression of the TFIIIB subunits Brf1 and Brf2, and (3) EGCG inhibits Brf2 promoter activity in cervical carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17624304      PMCID: PMC3010276          DOI: 10.1016/j.bbrc.2007.06.114

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  53 in total

1.  A stable complex of a novel transcription factor IIB- related factor, human TFIIIB50, and associated proteins mediate selective transcription by RNA polymerase III of genes with upstream promoter elements.

Authors:  M Teichmann; Z Wang; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

Review 2.  Tea polyphenols: prevention of cancer and optimizing health.

Authors:  H Mukhtar; N Ahmad
Journal:  Am J Clin Nutr       Date:  2000-06       Impact factor: 7.045

Review 3.  Integration of nutritional and stress signaling pathways by Maf1.

Authors:  Ian M Willis; Robyn D Moir
Journal:  Trends Biochem Sci       Date:  2006-12-14       Impact factor: 13.807

4.  Dietary polyphenols may affect DNA methylation.

Authors:  Mingzhu Fang; Dapeng Chen; Chung S Yang
Journal:  J Nutr       Date:  2007-01       Impact factor: 4.798

5.  Different human TFIIIB activities direct RNA polymerase III transcription from TATA-containing and TATA-less promoters.

Authors:  L Schramm; P S Pendergrast; Y Sun; N Hernandez
Journal:  Genes Dev       Date:  2000-10-15       Impact factor: 11.361

6.  Alternatively spliced hBRF variants function at different RNA polymerase III promoters.

Authors:  V McCulloch; P Hardin; W Peng; J M Ruppert; S M Lobo-Ruppert
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

Review 7.  Molecular targets for the cancer preventive activity of tea polyphenols.

Authors:  Chung S Yang; Joshua D Lambert; Zhe Hou; Jihyeung Ju; Gang Lu; Xinpei Hao
Journal:  Mol Carcinog       Date:  2006-06       Impact factor: 4.784

8.  Mammalian Maf1 is a negative regulator of transcription by all three nuclear RNA polymerases.

Authors:  Sandra S Johnson; Cheng Zhang; Jody Fromm; Ian M Willis; Deborah L Johnson
Journal:  Mol Cell       Date:  2007-05-11       Impact factor: 17.970

9.  RNA polymerase III transcription is repressed in response to the tumour suppressor ARF.

Authors:  Jennifer P Morton; Theodoros Kantidakis; Robert J White
Journal:  Nucleic Acids Res       Date:  2007-04-16       Impact factor: 16.971

10.  Human Maf1 negatively regulates RNA polymerase III transcription via the TFIIB family members Brf1 and Brf2.

Authors:  Janet Rollins; Ingrid Veras; Stephanie Cabarcas; Ian Willis; Laura Schramm
Journal:  Int J Biol Sci       Date:  2007-05-01       Impact factor: 6.580

View more
  13 in total

1.  Gender Specific Differences in RNA Polymerase III Transcription.

Authors:  N Diette; J Koo; S Cabarcas-Petroski; L Schramm
Journal:  J Carcinog Mutagen       Date:  2016-01-29

2.  Going Green: The Role of the Green Tea Component EGCG in Chemoprevention.

Authors:  Laura Schramm
Journal:  J Carcinog Mutagen       Date:  2013-05-20

3.  Inhibition of U6 snRNA Transcription by PTEN.

Authors:  Stephanie Cabarcas; Kounosuke Watabe; Laura Schramm
Journal:  Online J Biol Sci       Date:  2010-09-30

4.  INMAP, a novel truncated version of POLR3B, represses AP-1 and p53 transcriptional activity.

Authors:  Zhou Yunlei; Chen Zhe; Lei Yan; Wang Pengcheng; Zheng Yanbo; Sun Le; Liang Qianjin
Journal:  Mol Cell Biochem       Date:  2012-11-04       Impact factor: 3.396

5.  Overexpression of TFIIB-related factor 2 is significantly correlated with tumor angiogenesis and poor survival in patients with esophageal squamous cell cancer.

Authors:  Ming Lu; Hui Tian; Weiming Yue; Lin Li; Shuhai Li; Lei Qi; Wensi Hu; Cun Gao; Libo Si
Journal:  Med Oncol       Date:  2013-04-02       Impact factor: 3.064

Review 6.  RNA polymerase III transcription in cancer: the BRF2 connection.

Authors:  Stephanie Cabarcas; Laura Schramm
Journal:  Mol Cancer       Date:  2011-04-25       Impact factor: 27.401

7.  Differential expression of the TFIIIB subunits Brf1 and Brf2 in cancer cells.

Authors:  Stephanie Cabarcas; Joby Jacob; Ingrid Veras; Laura Schramm
Journal:  BMC Mol Biol       Date:  2008-08-12       Impact factor: 2.946

8.  TFIIB-related factor 2 over expression is a prognosis marker for early-stage non-small cell lung cancer correlated with tumor angiogenesis.

Authors:  Ming Lu; Hui Tian; Weiming Yue; Lin Li; Shuhai Li; Lei Qi; Wensi Hu; Cun Gao; Libo Si
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

9.  TFIIB-related factor 2 is associated with poor prognosis of nonsmall cell lung cancer patients through promoting tumor epithelial-mesenchymal transition.

Authors:  Yu Tian; Ming Lu; Weiming Yue; Lin Li; Shuhai Li; Cun Gao; Libo Si; Lei Qi; Wensi Hu; Hui Tian
Journal:  Biomed Res Int       Date:  2014-03-17       Impact factor: 3.411

10.  Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein.

Authors:  Jana Koo; Stephanie Cabarcas-Petroski; John L Petrie; Nicole Diette; Robert J White; Laura Schramm
Journal:  BMC Cancer       Date:  2015-11-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.